Monday's top analyst upgrades and downgrades included Ally Financial, Callaway Golf, Infinera, Lithia Motors, Microsoft, Nike, SolarWinds, Tapestry and Walmart.
A new Stifel research report includes the firm's biotech stock picks for 2021. These five have the biggest upside to the posted price targets and are best suited for patient, aggressive growth investors.
These four sizzling biotech stocks trading under the $10 level could provide investors with some solid upside potential. They are all Buy rated at Goldman Sachs, one of the top firms on Wall Street.
Friday's top analyst upgrades and downgrades included Airbnb, Aurora Cannabis, DoorDash, Dow, FedEx, Kohl’s, Macy’s, Oracle, Palantir and ViacomCBS.
Given the volatile situations around the globe, and big foreign purchasing, the defense sector remains a good place to keep capital in growth portfolios. A new Goldman Sachs research report includes some top defense…
Thursday's top analyst upgrades and downgrades included AT&T, Boeing, ConocoPhillips, Gilead Sciences, Illumina, Lam Research, Raytheon Technologies and Yum Brands.
These four energy stocks are rated Buy at Goldman Sachs and make good sense for growth and income investors looking for steady income and upside potential. They are solid ways for investors to play…
Wednesday's top analyst upgrades and downgrades included Chipotle Mexican Grill, Etsy, Exxon Mobil, General Electric, Jazz Pharmaceuticals, Microsoft, Nikola, Palo Alto Networks, Pfizer and Twitter.
In a move that investors looking for more defensive ideas should applaud, the analysts at Goldman Sachs have added Bristol-Myers Squibb to the Americas Conviction List. Plus, here are four additional health care stocks…
Tuesday's top analyst upgrades and downgrades included Baker Hughes, Bristol Meyers, Chevron, Emerson, Halliburton, HCA, Intuitive Surgical, Medtronic, NXP Semiconductors and Phillips 66.
These five dividend-paying stocks have solid growth potential and can deliver solid total return. The companies have very strong and defensible business models and products. So their stocks make sense for investors looking for…
A new Jefferies research report suggests the firm's forecasts for the semiconductor industry for the first half of 2021 could end up proving to be very conservative. Here are five picks for investors looking…
Antero Resources is among this week's picks of stock trading for less than $10 that are Buy-rated and have sizable upside potential. They are suited for aggressive investors looking to get some share-count leverage.
Investors have a chance to buy five top stocks with huge dividends payouts at discount pricing. Even if recovery in the share prices takes a while, the high dividends will make the wait more…
Rotating from overbought and crowded momentum stocks makes sense now. From a total return standpoint, dividend-paying large-cap pharmaceutical stocks may be one of the best ideas for 2021.
Goldman Sachs raises the price targets on stocks of some companies that delivered the goods in a big way during earnings season. These three have been absolutely on fire and remain great ideas for…
In what can only be described as either the most courageous call or the biggest sign of a market top ever, BofA Securities has added Broadcom to its US 1 list of top stocks…
When investors are this optimistic, it usually portends a sizable downturn. These five consumer staples companies always remain popular with consumers, and their stocks make sense for growth investors looking to shift to safer…
Here are five small-cap tech stocks for very aggressive investors looking to get share-count leverage with stocks that have sizable upside potential. They could very well offer patient investors some huge returns in 2021…
Friday's top analyst upgrades and downgrades included Ally Financial, Boeing, Cracker Barrel Old Country Store, Dish Network, FedEx, Marvell Technology, Prudential, Stitch Fix and Teladoc Health.
